Attività di ricerca
Ultime pubblicazioni:
-
Gentileschi, S., Gaggiano, C., Placido, F., Terribili, R., Cometi, L., Lopalco, G., et al. (2026). A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian study. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 18 [10.1177/1759720x261442376]. - dettaglio
-
Gentileschi, S., Terribili, R., Gaggiano, C., Fiorentini, E., Cometi, L., Cigolini, C., et al. (2026). Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study. SCIENTIFIC REPORTS, 16(1) [10.1038/s41598-026-37835-x]. - dettaglio
-
Gavioli, F., Caggiano, V., Sbalchiero, J., Frassi, M., Crisafulli, F., Cavazzana, I., et al. (2026). VEXAS syndrome and cancer: Insights about a possible “Tip of the Iceberg”. Ambidirectional data from the international AIDA network registries. SEMINARS IN ARTHRITIS AND RHEUMATISM, 77 [10.1016/j.semarthrit.2026.152932]. - dettaglio
-
Vitale, A., Caggiano, V., Sbalchiero, J., Lopalco, G., Tufan, A., Ragab, G., et al. (2026). Long-term remission and monocyclic course in Still’s disease patients starting canakinumab early: data from the international AIDA network registry. SEMINARS IN ARTHRITIS AND RHEUMATISM, 80 [10.1016/j.semarthrit.2026.153030]. - dettaglio
-
Caggiano, V., Sbalchiero, J., Frassi, M., Martin-Nares, E., Hinojosa-Azaola, A., Sikora, M., et al. (2026). Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries. FRONTIERS IN MEDICINE, 12 [10.3389/fmed.2025.1659758]. - dettaglio
